✦ LIBER ✦

Current status of epigenetic treatment in myelodysplastic syndromes

✍ Scribed by Andrea Kuendgen; Michael Lübbert

Publisher: Springer
Year: 2008
Tongue: English
Weight: 206 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0477-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic Hematopoietic Cell Transplant

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: Current Status

✍ H. Joachim Deeg; Matthias Bartenstein 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 314 KB

Iron status and treatment modalities in

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes

✍ Delforge, Michel (author);Selleslag, Dominik (author);Triffet, Agnès (author);Mi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 438 KB

Iron status and treatment modalities in

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes

✍ Delforge, Michel (author);Selleslag, Dominik (author);Triffet, Agnès (author);Mi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 438 KB

The treatment of the myelodysplastic syn

The treatment of the myelodysplastic syndromes

✍ Harvey D. Preisler 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ͻ 60 years. Thirty-two patients wi

Evolving treatment options of myelodyspl

Evolving treatment options of myelodysplastic syndromes

✍ W. Verbeek; A. Ganser 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 70 KB

A strategy for erythropoietin treatment

A strategy for erythropoietin treatment in myelodysplastic syndromes

✍ R Hast 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 274 KB